|
C-MAP™
Canadian Drug Benefit Plans Reference Guide -
2010 Edition
C-MAP™ Canadian Drug Benefit Plans Reference Guide 2010
Edition.
The new features of the 2010 Edition:
- The PMPRB section is extensively enhanced to include highlights of the revised Guidelines to be implemented on January 1, 2010 and latest changes in the PMPRB processes. The section will present more in depth details on the PMPRB rules and regulations.
The Canadian Market Access for
Pharmaceuticals (C-MAP™) Canadian Drug Benefit Plans
Reference Guide 2010 Edition provides detailed
information on the formulary listing policies and procedures
of the ten provincial prescription drug programs and
includes separate chapters on four federal drug programs.
There are also detailed overviews of the Provincial Cancer
Programs, the Joint Oncology Drug Review, the Patented
Medicine Prices Review Board (PMPRB), the Canadian Agency
for Drugs and Technologies in Health (CADTH), Federal/
Provincial/ Territorial Initiatives, and the private drug
plans in Canada. An extensive section on the Common Drug
Review (CDR) provides a comprehensive description of the CDR
process including CDR rationale for Canadian Expert Drug
Advisory Committee (CEDAC) decisions, time to decision
tracking of submissions and CDR submission forms and
templates available online. The executive summary provides
essential facts on each of the drug plans in convenient
tabular format. The 2010 Edition also includes new sections
on Blood Agencies and Public Health Vaccines.
This publication is divided into a
two-volume set. Volume 1 contains comprehensive details of
the various Canadian drug benefit plans. Volume 2 provides
formulary submission requirements, deadlines, contacts and
checklists for CDR and non-CDR submissions.
Login to C-MAP™ Canadian Drug Benefit Plans
|
